ISSN 0102-3616 printed version
ISSN 1982-4378 online version



Thank you for contributing to Revista Brasileira de Ortopedia. Please read the instructions carefully and observe all the
directions given. Failure to do so may result in unnecessary delays in publishing your article.

APC Type

2020 Article Processing Charge (APC)


None (Society Funded)


Find out more about Open Access at Thieme at


All manuscripts must be submitted at the following link:

    - All authors: full name, department, affiliation
    - Corresponding author: full name, degrees, department, affiliation, mailing address, telephone and fax number, e-mail address
    - Must be digital - hard copy submissions are not accepted
    - See the section Article Types for word limit
    - Cited sequentially in Vancouver
    - Cited sequentially in the main document, must be saved separately from the main document
    - Must be saved separately from the main document
    - Required if you plan to reproduce content from a published source or include a photograph of a patient
    - Patient permission form forms available at

The Revista Brasileira de Ortopedia (RBO) is the Official Scientific Publication of the Brazilian Society of Orthopedics and Traumatology (Sociedade Brasileira de Ortopedia e Traumatologia, SBOT) and it aims to disseminate papers that contribute towards improving and developing the practice, research and teaching of orthopedics and related specialties. It is published bimonthly in February, April, June, August, October and December, and has been published regularly since its first edition in 1965. The journal is dedicated to orthopedists who are linked to the SBOT, healthcare professionals who are dedicated to similar activities and orthopedists in other countries.


Article Types
The following graph shows what types of articles are accepted for publication, and what requirement they may have.

Article Type

Abstract Limit

Keywords Limit

Title Limit



Original Article
(Up to 2,500 words)

Up to 250 words


not applicable

10 Figures
e 6 Tables

Up to 30

Update Articles
(Up to 4,000 words)

Up to 250 words


not applicable

3 Figures and
2 Tables

Up to 60

Systematic Reviews and Meta-analysis
(Up to 4,000 words)

Up to 250 words


not applicable

3 Figures
e 2 Tables

Up to 60

Case Report
(Up to1,000 words)

Up to 250 words


not applicable

5 Figures

Up to 10

Technical Notes
(Up to 1,500 words)

Up to 250 words


not applicable

5 Figures
e 2 Tables

Up to 8

Letters to the Editor
(Up to 500 words



not applicable

2 Figures

Up to 4

Editorial (Up to 500 words)



not applicable



Original Article: It describes prospective or retrospective experimental research or clinical investigations, which may be randomized or double blind. It should have a Title, Structured Abstract (Objective, Methods, Results, and Conclusion), keywords, introduction, materials and methods, results, discussion, conclusions and references. Can have maximum of 6 authors. Maximum of 2,500 words, 30 references, 10 figures and 6 tables.
Update Articles: These are reviews of the state of the art on a given topic, written by specialists on invitation from the Editor-in-Chief. They should have Title, Unstructured abstract keywords, and references. Maximum of 4,000 words, 60 references, 3 figures and 2 tables.
Systematic Reviews and Meta-analysis: These have the purpose of examining the published bibliography on a given subject, in order to make a critical and systematized assessment on a certain specific topic and present the important conclusions based on this literature. They should have Title, an Unstructured abstract, keywords, and references. Maximum of 4,000 words, 60 references, 3 figures and 2 tables.
Case Report: It should be informative and should not contain irrelevant details. Only clinical case reports of interest, either for its rarity as a nosological entity, or for the unusual form of presentation. It should have a title,  unstructured abstract, keywords and references. Maximum of 1,000 words, 10 references, 5 figures.
Technical Note: Intended for the disclosure of diagnostic method or experimental surgical technique, new surgical instruments, orthopedic implants, etc. Must have: Title; unstructured abstract; Keywords; Explanatory Introduction, Method, Material or Technique Description, Final Comments and References. Maximum of 1.500 words, 8 references, 5 figures and 2 tables.
Letters to the Editor: These have the aim of commenting on or discussing studies published in the journal or reporting on original research that is in progress. They will be published at the editors' discretion, with the respective reply, when appropriate.
Editorial: These are written on invitation from the Editor-in-Chief, presenting comments on important studies in this journal, describing important published research or presenting communications from the editors that are of interest to the specialty.

General Guidelines

  • You must submit a digital copy of your manuscript. Hard copy submissions are not accepted.
  • Keep the format of your manuscript simple and clear. We will set your manuscript according to our style—do not try to “design” the document.
  • The manuscript, including the title page, abstract and keywords, text, references, figure captions, and tables should be typewritten, double-spaced in 12-point font with 1-inch margins all around and saved as one file.
  • Each figure should be saved as its own separate file. Do not embed figures within the manuscript file. This requires special handling by Thieme’s Production Department.
  • Keep abbreviations to a minimum and be sure to explain all of them the first time they are used in the text.
  • The manuscripts should be written in consistent British or American English.
  • The authors should use Système International (SI) measurements. For clarity, nonmetric equivalents may be included in parentheses following the SI measurements.
  • Use generic names for drugs. You may cite proprietary names in parentheses along with the name and location of the manufacturer.
  • Credit suppliers and manufacturers of equipment, drugs, and other brand-name material mentioned in the manuscript within parentheses, giving the company name and primary location.

Files/Information Checklist:

  • One of the authors can be designated as the corresponding author. The e-mail address and full postal address should be included in the title page. For more details, please see below the section of Title Page.
  • Manuscript:
    • Include Keywords
    • All relevant Figures and their Figure captions/legends
    • All Tables (including titles, description, footnotes)
    • Ensure all figure and table citations in the text match the files provided
    • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (wherever applicable)
    • Supplemental files (wherever applicable)
  • Further considerations
    • Manuscript has been ‘spell checked’ and ‘grammar checked’
    • All references mentioned in the Reference List are cited in the text, and vice versa
    • Permission has been obtained for use of copyrighted material from other sources (including the Internet)
    • A competing interests statement is provided, even if the authors have no competing interests to declare
    • Journal policies detailed in this guide have been reviewed
    • Referee suggestions and contact details provided, based on journal requirements

Articles can be written in Portuguese or English.

Title Page

  • This journal adheres to a double-blinded peer-review policy. The title page should not be included in the main document and should be provided as a separate document.
  • Article Title: Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
  • Authorship: A maximum of 6 authors, except to the multicenter studies where the number of authors may be greater, as follows:
    - Two or three institutions, a maximum of 4 authors per institution;
    - More than four institutions, a maximum of 3 authors per institution.
    - Under no circumstances, the number of authors can be greater than 20.
  • Indicate professional qualification, academic degree and affiliation of each author, separately. If there is more than one institutional affiliation, indicate only the most relevant. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Present the authors’ affiliation addresses (where the actual work was done) below the each name, followed by the respective ORCID ( Indicate all affiliations with a lower-case superscript letter immediately after the author’s name and in front of the appropriate address. Provide the full postal address of each affiliation, including the city, state and country name and, if available, the e-mail address of each author. Author affiliations should be presented in increasing hierarchical order (e.g. Harvard University, Harvard Business School, Boston, USA) and should be written as established in its own language (e.g. Universit Paris-Sorbonne; Harvard University, Universidade de So Paulo).
  • Corresponding Author: Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.

Abstract and Keywords
See the section Article Types for word limits.
The abstract should briefly outline the content of the article and any conclusions it may reach. The keywords should be words a reader would be likely to use in searching for the content of the article.
A structured abstract, by means of appropriate headings, should provide the context or background for the research and should state its purpose, basic procedures (selection of study subjects or laboratory animals, observational and analytical methods), main findings (giving specific effect sizes and their statistical significance, if possible), and principal conclusions. It should emphasize new and important aspects of the study or observations.
The abstracts should be a maximum of 250 words and structured in the following format: Purpose: One or two sentences that simply state purpose with no background information. Methods: Provide details about the methods of the study, including data analysis. Results: Present most important findings of the study. Please provide numbers (means with standard deviations or medians with ranges) to support your findings, and results of significance tests, e.g. p-values. Conclusions: One or two sentences that state only what your study identified and actually demonstrated. Please do not include comments or information not supported by the data of your study. Level of Evidence (for human studies) or Clinical relevance (basic science in-vitro or in-vivo study: why is this study important from a clinical standpoint?).
Immediately after the abstract, provide a maximum of 6 keywords in alphabetical order and separated by semicolon, to represent the content of the article. The descriptors or keywords should be based on the Health Science Descriptors (Descritores em Cincias da Sade, DECS), which are available at the electronic address; or on the Medical Subject Headings (MeSH), from MBrowser.html. 


  • This journal uses double-blind peer-review, which means the identities of the authors are concealed from the reviewers, and vice versa. To facilitate this, please include the following separately:
    • Title page (with author details): This should include the title, authors’ names, affiliations, acknowledgements and any Declaration of Interest statement, and a complete address for the corresponding author including an e-mail address.
    • Blinded manuscript (no author details): The main body of the paper (including the references, figures, tables and any acknowledgements) should not include any identifying information, such as the authors’ names or affiliations.
  • Original Articles, Systematic Reviews and Meta-analyses, the text should be structured in the standard IMRAD (Introduction, Methods, Results, Discussion) format.
  • Papers including human or animal subjects must include a statement of approval by appropriate agencies in the text.
  • Use generic names of drugs or devices. If a particular brand was used in a study, insert the brand name along with the name and location of the manufacturer in parentheses after the generic name when the drug or device is first mentioned in the text.
  • Quantities and units should be expressed in accordance with the recommendations of the International System of Units (SI), 8th edition 2006 (www.bipm.orgutilscommonpdfsi_brochure_8_en.pdf).
  • When abbreviations are used, give the full term followed by the abbreviation in parentheses the first time it is mentioned in the text, such as inferior gleno-humeral ligament (IGHL).
  • Please clearly distinguish the hierarchy of headings within the manuscript by using capital letters, underline, italic, and bold styles as necessary.
  • As needed, use italic, superscripts, subscripts, and boldface, but otherwise do not use multiple fonts and font sizes.
  • Do not insert page or section breaks except where noted in the Author Instructions.
  • Use hard returns (the Enter key) only at the end of a paragraph, not at the end of a line. Allow lines of text to break automatically in your word-processing software. Do not justify your text.
  • Use only one space, not two, after periods.
  • Create tables using the Table function in Microsoft Word.

Thieme Editing Services
Thieme offers a language editing service for manuscripts, abstracts and theses in partnership with Enago, a world-leading provider of author services to researchers around the world. Authors can choose from a range of editing services and get their manuscripts edited by Enago’s professional medical editors. Authors that wish to use this service will receive a 20% discount on all editing services. To find out more information or get a quote, please visit

Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).

Formatting of Funding Sources
List funding sources in this standard way to facilitate compliance to funder’s requirements:
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].
It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding.
If no funding has been provided for the research, please include the following sentence:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of Interest
Please click to download a Conflict of Interest form.

References should be the most recent and pertinent literature available. It is essential that they are complete and thoroughly checked. If the reference information is incomplete, good online sites to search for full details are the National Library of Medicine:; Books in Print:; PubMed:; or individual publisher Web sites.

  • References must be listed in AMA style, using Index Medicus journal title abbreviations.
  • References follow the article text. Insert a page break between the end of text and the start of references.
  • References must be cited sequentially (NOT alphabetically) in the text using superscript numbers.
  • List all author names, up to and including six names. For more than six authors, list the first six followed by et al.
  • References should be styled per the following examples:

1. Citing a journal article:
Borges JLP, Milani C, Kuwajima SS, Laredo Filho J. Tratamento da luxação congênita de quadril com suspensório de Pavlik e monitorização ultra-sonográfica. Rev Bras Ortop 2002;37(1/2):5-12.
2. Citing a chapter in a book:
Johnson KA. Posterior tibial tendon. In: Baxter D. The foot and ankle in sport. St Louis: Mosby; 1995. p. 43-51
3. Citing a book:
Baxter D. The foot and ankle in sport. St Louis: Mosby; 1995
4. Citing a thesis:
Laredo Filho J. Contribuição ao estudo clínico-estatístico e genealógico-estatístico do pé torto congênito equinovaro [thesis]. São Paulo: Universidade Federal de São Paulo. Escola Paulista de Medicina; 1968
5. Citing a government publication:
Food and Drug Administration. Jin Bu Huan Herbal Tablets. Rockville, MD: National Press Office; April 15, 1994. Talk Paper T94-22
6. Citing an online article:
Lino Junior W, Belangero WD. Efeito do Hólmio YAG laser (Ho: YAG) sobre o tendão patelar de ratos após 12 e 24 semanas de seguimento. Acta Ortop Bras [periodical on the Internet] 2005 [cited 2005, Aug 27];13(2):[about 5 p.]. Available from: scielo
7. Citing a symposium article:
Eisenberg J. Market forces and physician workforce reform: why they may not work. Paper presented at: Annual Meeting of the Association of American Medical Colleges; October 28, 1995; Washington, DC

Figure Captions

  • Figures include photographs or radiographs, drawings, graphs, bar charts, flow charts, and pathways, but NOT lists or tables.
  • Figures must be cited sequentially in the text. Number all figures (and corresponding figure captions) sequentially in the order they are cited in the text.
  • Figure captions should be written after the reference list. Insert a page break between the end of references and the start of figure captions.
  • Figure captions should include a description of the figure and/or each lettered part (A, B, etc.) and of any portions of the figure highlighted by arrows, arrowheads, asterisks, etc.
  • For a figure borrowed or adapted from another publication (used with permission), add a credit line in parentheses at the end of each figure legend. This credit line should be a complete bibliographic listing of the source publication (as a reference), or other credit line as supplied by the copyright holder. For example (Reprinted with permission from Calfee DR, Wispelwey B. Brain abscess. Semin Neurol 2000;20:357.)


  • Data given in tables should be commented on but not repeated in the text. Be sure that lists or columns of related data are composed in a word-processing program like the rest of the text.
  • Do not intersperse tables in the text. Tables should appear after the figure captions. Insert a page break between the end of the figure captions and the start of the tables.
  • Tables must be double-spaced and numbered in the same sequence they are cited in the text. A short descriptive title should be provided for each table.
  • If a table contains artwork, supply the artwork separately as a digital file.
  • For tables borrowed or adapted from another publication (used with permission), add a credit line as the first footnote beneath each table. This credit line should be a complete bibliographical listing of the source publication (as a reference), or other credit line as supplied by the copyright holder. For example, “Reprinted with permission from Calfee DR, Wispelwey B. Brain abscess. Semin Neurol 2000;20:357.” (“Data from . . .” or “Adapted from . . .” may also be used, as appropriate.)
  • Other footnotes for tables should be indicated in the table using superscript letters in alphabetical order.
  • Any abbreviations used in the table should be explained at the end of the table in a footnote.


  • The following formats are acceptable: *.avi, *.mov and *.mpg.
  • For supplementary videos, the length should not exceed 4 minutes, and a legend of no more than 40 words per video or per sequence is required (it should also be included in the main document).
  • If  including a voice over, it must be in clear English. Be precise, informative, and clear in your speech. Re-record audio in post-production for sound quality.

Supplementary Material
Supplementary material such as applications, images and sound clips, can be published with your article to enhance it. Submitted supplementary items are published exactly as they are received (Excel or PowerPoint files will appear as such online). Please submit your material together with the article and supply a concise, descriptive caption for each supplementary file. If you wish to make changes to supplementary material during any stage of the process, please make sure to provide an updated file. Do not annotate any corrections on a previous version. Please switch off the ‘Track Changes’ option in Microsoft Office files as these will appear in the published version.


General Guidelines

  • It is best to use Adobe Photoshop to create and save images, and Adobe Illustrator for line art and labels.
  • Do not submit art created in Microsoft Excel, Word, or PowerPoint. These files cannot be used by the typesetter.
  • Save each figure in a separate file.
  • Do not compress files.
  • All black-and-white and color artwork should be at a resolution of 300 dpi (dots per inch) in TIFF format. Line art should be 1,200 dpi in EPS or TIFF format. Contact the Production Editor at Thieme if you are unsure of the final size.
  • It is preferable for figures to be cropped to their final size (approximately 3½ inches for a single column and up to 7 inches for a double column), or larger, and in the correct orientation. If art is submitted smaller and then has to be enlarged, its resolution (dpi) and clarity will decrease.

Note: Lower resolutions (less than 300 dpi) and JPEG format (.jpg extension) for grayscale and color artwork are strongly discouraged due to the poor quality they yield in printing, which requires 300 dpi resolution for sharp, clear, detailed images. JPEG format, by definition, is a lower resolution (compressed) format designed for quick upload on computer screens.

Black-and-White Art

  • Black-and-white artwork can be halftone (or grayscale) photographs, radiographs, drawings, line art, graphs, and flowcharts. Thieme will only accept digital artwork.
  • If possible, do not send color art for conversion to black-and-white. Do the conversion yourself so that you can check the results and confirm in advance that no critical details are lost or obscured by the change to black-and-white.
  • For best results, line art should be black on a white background. Lines and type should be clean and evenly dark. Avoid screens or cross-hatching, as they can darken or be uneven in printing and lead to unacceptable printing quality.

Color Art

  • All color artwork should be saved in CMYK, not RGB.

Art Labels

  • Arrows, asterisks, and arrowheads (or other markers) should be white in dark or black areas and black in light or white areas, and large in size. If not, these highlighting marks may become difficult to see when figures are reduced in size during the typesetting process.
  • Use 1-point (or thicker) rules and leader lines.
  • Capitalize the first word of each label and all proper nouns. Consider using all capitals if you need a higher level of labels.
  • Where there are alternate terms or spellings for a named structure, use the most common one and make sure it is consistent with what is used in the text.
  • Avoid using multiple fonts and font sizes for the labels; use only one or two sizes of a serif font.

Article Processing Charge (APC) & Open Access
This is a subsidized Open Access journal: all the articles after publishing online, will be immediately and permanently made free for everyone to read and download on Thieme-connect platform. The Brazilian Society of Orthopaedics and Traumatology (Sociedade Brasileira de Ortopedia e Traumatologia SBOT) pays for the publishing costs incurred by the journal. Authors do not have to pay any Article Processing Charge or Open Access Publication Fee. All peer- reviewed articles are published as open access in this journal. Permitted third party (re)use is defined by the following Creative Commons user licenses: Creative Commons Attribution-Non Commercial-No Derivs (CC BY-NC-ND)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

Submission Procedure

  • Consult the checklist on the first page of this document to ensure that you are ready to submit your manuscript.
  • Manuscripts must be submitted electronically at the following link:
  • Always review your manuscript before submitting it. You may stop a submission at any phase and save it to submit later. After submission, you will receive a confirmation email. You can also check the status of your manuscript by logging in to the submission system. The system converts your article files to a single PDF file used in the peer-review process. Editable files are required to typeset your article for final publication. All correspondence, including notification of the Editor’s decision and requests for revision, is sent by e-mail. The Editor in Chief will inform you via email once a decision has been made.

Revision Procedure

  • Should the editors decide that your article requires a revision, you will need to make the changes via a word-processing program and resubmit it electronically.
  • Log In to the submission system and find your article, which will be marked for revision.
  • The best way to make revisions to your manuscript is by enabling the Track Changes mode in Microsoft Word, which will automatically highlight and mark up revised text. Please submit both a marked up copy and a clean copy of your revised manuscript to the submission system.
  • Your original files will still be available after you upload your revised manuscript, so you should delete any redundant files before completing the submission.
  • You will also be provided space in which to respond to the reviewers’ and editors’ comments. Please be as specific as possible in your response.

Page Proofs
Page proofs will be sent to you via email. The proofs will be in a PDF file format, which should be opened using Acrobat Reader software. You will receive further instructions with your proofs. Take this opportunity to check the typeset text for typographic and related errors. Elective alterations are difficult to accommodate owing to the associated time and expense of introducing them. Therefore, please be sure that when you submit your manuscript, it is accurate, complete, and final.

Statement on Liability
The legislation on product liability makes increased demands on the duty of care to be exercised by authors of scientific research and medical publications. This applies in particular to papers and publications containing therapeutic directions or instructions and doses or dosage schedules. We therefore request you to examine with particular care, also in your own interest, the factual correctness of the contents of your manuscript once it has been copyedited and returned to you in the form of galley proofs. The responsibility for the correctness of data and statements made in the manuscript rests entirely with the author.

Definition of Authorship
Authorship credit should be based on criteria established by the International Committee of Medical Journal Editors. Each author should have made the following contributions towards the completion of the manuscript:

  • Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data
  • Drafting the article or revising it critically for important intellectual content
  • Final approval of the version to be published

Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure.

Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

Copyright Statement
Submitted manuscripts must represent original research not previously published nor being considered for publication elsewhere. The editors and Thieme combat plagiarism, double publication, and scientific misconduct with the software CrossCheck powered by iThenticate. Your manuscript may be subject to an investigation and retraction if plagiarism is suspected.
If you plan to reproduce text, tables, or figures from a published source, you must first obtain written permission from the copyright holder (usually the publisher). This is required even if the material is from your own published work. For material never before published and given to you by another person, you must obtain permission from that person. Serious delays to publication can be incurred if permissions are not obtained.
As the author, it is your responsibility to obtain all permissions, pay any permission fees, furnish copies of permissions to Thieme with your manuscript, and include a credit line at the end of the figure caption, beneath the table, or in a text footnote.
Upon publication of an article, all rights are held by the publishers, including the rights to reproduce all or part of any publication. The reproduction of articles or illustrations without prior consent from the publisher is prohibited.

Declaration of Interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications /registrations, and grants or other funding. In addition to providing the duly filled and signed ICMJE COI Forms, authors must disclose any interests in two places:

1. A summary declaration of interest statement in the title page file. If there are no interests to declare then please state this: ‘Declarations of interest: none’. This summary statement will be ultimately published if the article is accepted.
2. Detailed disclosures as part of a separate ICMJE COI Forms, as stated above - which forms part of the journal’s official records. It is important for potential interests to be declared in both places and that the information matches.

Role of the Funding Source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. 

Statement of Ethics
This journal adheres to the ethical standards described by the Committee on Publication Ethics and the International Committee of Medical Journal Editors. Authors are expected to adhere to these standards.
For all manuscripts reporting data from studies involving human or animal participants, formal review and approval, or formal review and waiver (exemption), by an appropriate institutional review board (IRB) or ethics committee is required, as well as any necessary HIPAA consent, and should be described in the Methods section with the full name of the reviewing entity. All clinical trials must be registered in a public trials registry. Denote the registry and registry number.

Patient Permission Policy (
You must obtain a signed patient permission form for every patient whose recognizable photograph will be used. If you do not supply this, the identity of the patient must be obscured before the image is published; this could interfere with the instructive value of the photograph. Patient permission forms are available at Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed. All animal experiments should comply with the local guidelines and the authors should clearly indicate in the manuscript that such guidelines have been followed.

Protection of Human and Animal Subjects
All manuscripts must include language either describing the steps taken to protect human and/or animal subjects, or a statement acknowledging that human and/or animal subjects were not included in the project, according to the Declaration of Helsinki. An example of basic language for human subjects protections would be: “The study was performed in compliance with the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects, and was reviewed by XXX Institutional Review Board.”

Please contact the Editors or Thieme Publishers with any questions.

Editor in Chief
Prof. Dr. Sergio L Checchia, MD, PhD
Sociedade Brasileira de Ortopedia e Traumatologia
Alameda Lorena, 427 - 2o. Andar - Jd. Paulista, SP, Brasil
T: +55 11 2137 5400

Thieme Publishers – Production Editor
Leonardo Vidal
Editor de Produção - Journals
Thieme Revinter Publicações Ltda.
T: +55 21 2563 9734

Thieme Publishers – Acquisition Editor
Ana Paula Canel Bluhm
Acquisition Editor - Journals
T: +55 11 3362 2464


[Home] [About this journal] [Editorial board] [Subscription]

Creative Commons License All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License

Al. Lorena, 427 14º andar - Jd. Paulista
01424-000 São Paulo SP Brasil
Tel.:(11) 2137-5417